Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Bioprosthetic Valve Fracture During Valve-in-valve TAVR: Bench to Bedside
Author(s): John T Saxon , Keith B Allen , David J Cohen , et al Added: 3 years ago
Surgical aortic valve replacement (SAVR) has long been the standard of care for aortic valve replacement. More recently, transcatheter aortic valve replacement (TAVR) has been established as a safe, effective and less invasive method of valve replacement in patients with severe aortic stenosis who are at intermediate or high risk for complications related to SAVR.1–4 For patients who present with… View more

Vascular Disease and Surgery

Intervention
TCT 22: PARTNER 3: SAPIEN 3 Valve For Failed Aortic Bioprosthetic Valves
Author(s): Santiago Garcia Added: 1 year ago
TCT 22 - Dr Santiago Garcia (Minneapolis Heart Institute at Abbott Northwestern Hospital, MN, US) joins us to discuss the findings of a substudy of the PARTNER 3 Trial which aimed to evaluate the safety and efficacy of Edwards' SAPIEN 3 Ultra transcatheter heart valve in aortic stenosis patients with a failing bioprosthetic valve. In this study, 125 patients received TAVR using the Sapien 3… View more

Intervention
USC Discussion 2022: Valve-in-Valve TAVR for Failed Surgical Valves
Author(s): Kendra J Grubb , Isida Byku Added: 1 year ago
In this USC Discussion, Special Focus Editor Dr Kendra Grubb (Emory Structural Heart and Valve Center, US) is joined by Dr Isida Byku (Emory School of Medicine, Druid Hills, GA, US) to discuss her recent review article,"Valve-in-valve Transcatheter Aortic Valve Replacement for Failed Surgical Valves and Adjunctive Therapies". Discussion Points: 22s: How many patients are affected by failed TAVR… View more

Intervention
USC Discussion 2022: The Multidisciplinary Heart Team in AS
Author(s): Kendra J Grubb , Suzanne J Baron Added: 1 year ago
Bringing surgery and interventional cardiology together, Dr Suzanne Baron (Lahey Health, US)and her team published a review article on “The Evolving Role of the Multidisciplinary Heart Team in Aortic Stenosis”, in a comprehensive special focus issue on the “Lifetime Management of Patients With Aortic Stenosis” edited by Dr Kendra Grubb (Emory Structural Heart and Valve Center, US). In this… View more

Vascular Disease and Surgery

Intervention
Kendra J Grubb
Research Area(s) / Expertise: Job title: Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine. Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease. Her… View more
Bioprosthetic Aortic Valve Fracture During Valve-in-valve Transcatheter Aortic Valve Implantation
Author(s): John Phineas O’Donnell , Crochan J O’Sullivan Added: 3 years ago
The demand for replacing degenerated bioprosthetic valves (BPVs) is steadily rising owing to the increasing burden of heart disease, ageing populations, advances in surgical intervention and limited durability of current-generation surgical BPVs. The issue is exacerbated by the increasing trend of surgical BPV replacement, especially in younger patients who are likely to require future… View more

Vascular Disease and Surgery

Intervention
Balloon Pre-dilation and Post-dilation in TAVR
Author(s): Angela McInerney , Rafael Vera-Urquiza , Gabriela Tirado-Conte , et al Added: 2 years ago

Intervention
Transcatheter aortic valve replacement update in bicuspid aortic valve disease
Author(s): Nicolas M Van Mieghem , Basel Ramlawi , Didier Tchétché , et al Start date: Jun 04, 2020

Intervention
Transcatheter Aortic Valve Replacement for Native Aortic Valve Regurgitation
Author(s): Roberto Spina , Chris Anthony , David WM Muller , et al Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) with either the balloonexpandable Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, California), or the self-expandable CoreValve prosthesis (Medtronic, Minneapolis, Minnesota) has become the established therapeutic modality for severe aortic valve stenosis in patients who are not deemed suitable for surgical intervention due to excessively high… View more

Vascular Disease and Surgery

Intervention